GENETHERA, INC. ISSUES COMMENTS ON THE FIRST INTERNATIONAL RESEARCH SYMPOSIUM ON MAP AND CROHN'S DISEASE. WESTMINSTER, Colo., Sept. 29, 2015 (GLOBE NEWSWIRE) -- GeneThera, Inc. (OTC: GTHR) as a service to its shareholders and the general public is pleased to release comments on the first Symposium on...